ABMC — American Bio Medica Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $0.11m
- $0.91m
Annual balance sheet for American Bio Medica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
| 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.113 | 0.004 | 0.098 | 0.115 | 0.034 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.452 | 0.37 | 0.407 | 0.723 | 0.284 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.61 | 1.22 | 1.18 | 1.34 | 0.769 | 
| Net Property, Plant And Equipment | 0.718 | 0.717 | 0.617 | 0.522 | 0.479 | 
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 2.48 | 2.08 | 1.93 | 1.88 | 1.27 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 1.82 | 1.69 | 2.02 | 2.82 | 3.6 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.62 | 2.87 | 3.18 | 2.83 | 3.61 | 
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.146 | -0.79 | -1.26 | -0.944 | -2.34 | 
| Total Liabilities & Shareholders' Equity | 2.48 | 2.08 | 1.93 | 1.88 | 1.27 | 
| Total Common Shares Outstanding |